Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
IMPAX LABORATORIES, Inc. (NQ: IPXL)
18.80 USD  +0.20 (+1.08%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about IMPAX LABORATORIES, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Impax Laboratories to Present at the Deutsche Bank 38th Annual Health Care Conference
Today 9:15 EDT
from Business Wire News Releases
Pre-Market Analysis on STSI, IPXL, PCYC, and UTHR
May 21, 2013
from ACCESSWIRE
Impax Board of Directors Establishes Compliance Committee
May 20, 2013
from Business Wire News Releases
Impax Laboratories to Present at the UBS Global Healthcare Conference
May 20, 2013
from Business Wire News Releases
Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.
May 17, 2013
from Business Wire News Releases
(ADS) Shire Beats Earnings in First Quarter
May 16, 2013
Shire’s (SHPG) first quarter 2013 earnings (excluding special items) of 1.63 as per American... Visit StockBlogHub to view complete post. Read More
category IPXL , Alliance Data Systems Corporation , ONXX , and 5 more.
from Stock Blog Hub
(IPXL) Impax Laboratories Beats Earnings Estimate
May 15, 2013
Impax Laboratories Inc.’s (IPXL) first quarter 2013 adjusted earnings of 37 cents per share were... Visit StockBlogHub to view complete post. Read More
category Glaxosmithkline plc , Transcept Pharmaceuticals Inc , CPRX , and 7 more.
from Stock Blog Hub
UPDATE 1-FDA allows generic forms of Endo Health's Opana ER painkiller
May 10, 2013
May 10 (Reuters) - The U.S. Food and Drug Administration on Friday denied Endo Health Solutions' petition to block generic forms of its widely abused prescription pain drug Opana ER, a surprise... Read More
category companyNews
from Reuters: Company News
FDA allows generic forms of Endo Health's Opana ER painkiller
May 10, 2013
May 10 (Reuters) - The U.S. Food and Drug Administration on Friday denied Endo Health Solutions' petition to block generic forms of its widely abused prescription pain drug Opana ER, a surprise... Read More
category companyNews
from Reuters: Company News
Impax Labs (IPXL), Zogenix (ZGNX) Rise as FDA Won't Block Generic Opana (ENDP)
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8327739 for the full story. Read More
from StreetInsider.com News Articles
Impax Laboratories to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
from Business Wire News Releases
Insiders Bullish on Certain Holdings of XPH
May 03, 2013
A look at the weighted underlying holdings of the SPDR S&P Pharmaceuticals ETF (XPH) shows an impressive 12.1% of holdings on a weighted basis have experienced insider buying within the past six... Read More
category ETFs
from ETF Channel
IMPAX LABORATORIES 96 HOUR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Lead Plaintiff Motion Deadline in Securities Class Act
May 02, 2013
from Business Wire News Releases
UPDATE 1-Shire cuts sales forecast as some drugs miss Q1 targets
May 02, 2013
LONDON, May 2 (Reuters) - Pharmaceutical firm Shire managed to squeeze out a first-quarter earnings beat on Thursday thanks to cost controls after sales of some of its drugs, notably rare disease... Read More
category companyNews
from Reuters: Company News
Shire delivers Q1 earnings beat on strong product sales
May 02, 2013
LONDON, May 2 (Reuters) - British pharmaceutical firm Shire beat expectations with a 10 percent rise in first-quarter earnings on Thursday after a strong performance from its drugs that treat... Read More
category companyNews
from Reuters: Company News
Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 16c
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8295713 for the full story. Read More
from StreetInsider.com News Articles
Impax Laboratories Reports First Quarter 2013 Results
May 01, 2013
from Business Wire News Releases
Impax Laboratories Inc (NASDAQ:IPXL) Investor Alert: Lawsuit Deadline in the Lawsuit on May 6
May 01, 2013
San Diego, CA -- (SBWIRE) -- 05/01/2013 -- A deadline is coming up on May 6, 2013 in the lawsuit filed for investors of Impax Laboratories Inc (NASDAQ:IPXL) over alleged violations of Federal... Read More
from SBWire - Latest Press Releases
Trading Radar for 05/01: Facebook (FB), Clorox (CLX), MasterCard (MA), Chesapeake (CHK), Time Warner (TWX), Sands (LVS) Report
April 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8291891 for the full story. Read More
from StreetInsider.com News Articles
Impax Laboratories Has Returned 28.6% Since SmarTrend Recommendation (IPXL)
April 30, 2013
from Comtex SmarTrend® News Briefs
Impax (IPXL), Glaxo (GSK) Terminate Ex. U.S., Taiwan IPX066 Collaboration
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8284469 for the full story. Read More
from StreetInsider.com News Articles
Impax Pharmaceuticals and GlaxoSmithKline Terminate Their Collaboration on IPX066 (RYTARYTM)
April 29, 2013
from Business Wire News Releases
Law Offices of Howard G. Smith Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Impax Laboratories, Inc. -- IPXL
April 28, 2013
from GlobeNewswire News Releases
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Impax Laboratories Inc. of Class Action Lawsuit and the Deadline of May 6, 2013 to Seek a Lead Plaintiff Posit
April 23, 2013
from PR Newswire
(WCRX) Warner Chilcott Earns Good News from US Food and Drug Administration
April 23, 2013
Warner Chilcott plc (WCRX) recently received encouraging news from the US Food and Drug... Visit StockBlogHub to view complete post. Read More
category Mylan Inc/ , Warner Chilcott Limited , QLTI , and 7 more.
from Stock Blog Hub
Impax Laboratories Has Returned 29.5% Since SmarTrend Recommendation (IPXL)
April 23, 2013
from Comtex SmarTrend® News Briefs
Glancy Binkow & Goldberg Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Impax Laboratories, Inc. -- IPXL
April 19, 2013
from GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Impax Laboratories Inc. of Class Action Lawsuit and the Deadline of May 6, 2013 to Seek a Lead Plaintiff Posit
April 16, 2013
from Business Wire News Releases
Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCall's Microscope
April 16, 2013
from PR Newswire
Impax Laboratories Down 34.4% Since SmarTrend Downtrend Call (IPXL)
April 15, 2013
from Comtex SmarTrend® News Briefs
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Google and NASA Make Quantum Leap With New Computer
Josh Wolonick
2
Random Thoughts: The Third Dip Cometh!
Todd Harrison
3
Google, Facebook, Yahoo, and Twitter: Web Giants Make Unexpected Announcements
Carol Kopp
4
Mother of All Fed Cha-Cha Days or Last Tango on Wall Street?
Jeffrey Cooper
5
'Pitches Are Like Blind Dates': The 11 Things Top Investors Want Startup CEOs to Know
Nick Shchetko